売上総利益、Impairment LossEL - Pharmaceutical Products Reportable Segments Member、Interest On BondsNOE他1件
- 【期間】
| 年度 | 売上総利益 | Impairment LossEL - Pharmaceutical Products Reportable Segments Member | Interest On BondsNOE | Depreciation Segment Information - Construction Contracting Reportable Segment Member |
|---|
| 2010/09 | 213億 | | - | | - | | - | |
| 2011/09 | 206億 | -3.4% | - | | - | | - | |
| 2012/09 | 201億 | -2.2% | - | | - | | - | |
| 2013/09 | 216億 | +7.2% | - | | - | | - | |
| 2014/09 | 230億 | +6.4% | - | | - | | - | |
| 2015/09 | 228億 | -0.6% | - | | - | | - | |
| 2016/09 | 232億 | +1.8% | - | | - | | - | |
| 2017/09 | 243億 | +4.4% | - | | - | | - | |
| 2018/09 | 222億 | -8.7% | - | | - | | - | |
| 2019/09 | 187億 | -15.6% | - | | - | | - | |
| 2020/09 | 161億 | -13.9% | - | | - | | - | |
| 2021/09 | 155億 | -3.9% | - | | - | | - | |
| 2022/09 | 162億 | +4.7% | - | | - | | - | |
| 2023/09 | 183億 | +13.1% | - | | - | | - | |
